Short Interest in Jaguar Health, Inc. (NASDAQ:JAGX) Expands By 32.5%

Jaguar Health, Inc. (NASDAQ:JAGXGet Free Report) saw a significant increase in short interest during the month of January. As of January 31st, there was short interest totalling 785,100 shares, an increase of 32.5% from the January 15th total of 592,700 shares. Based on an average daily trading volume, of 436,600 shares, the days-to-cover ratio is currently 1.8 days. Currently, 7.9% of the shares of the company are short sold.

Institutional Inflows and Outflows

An institutional investor recently bought a new position in Jaguar Health stock. Virtu Financial LLC acquired a new position in shares of Jaguar Health, Inc. (NASDAQ:JAGXFree Report) during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 25,591 shares of the biotechnology company’s stock, valued at approximately $35,000. Virtu Financial LLC owned 0.22% of Jaguar Health at the end of the most recent reporting period. 12.04% of the stock is currently owned by institutional investors and hedge funds.

Jaguar Health Trading Up 5.3 %

Shares of NASDAQ:JAGX traded up $0.04 during trading on Friday, reaching $0.90. The company had a trading volume of 358,118 shares, compared to its average volume of 329,583. The company has a current ratio of 1.84, a quick ratio of 1.36 and a debt-to-equity ratio of 1.65. The stock’s fifty day moving average price is $0.95 and its 200 day moving average price is $1.06. Jaguar Health has a fifty-two week low of $0.78 and a fifty-two week high of $21.60.

Jaguar Health Company Profile

(Get Free Report)

Jaguar Health, Inc, a commercial stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress, specifically chronic and debilitating diarrhea. The company operates through two segments, Human Health and Animal Health. It focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products.

Featured Articles

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.